Granules India Ltd.
Snapshot View

356.60 -1.25 ▼-0.4%

25 November 2022, 04:14:06 PM
Volume: 341,096

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.granulesindia.com
Market Cap 8,627.61 Cr.
Enterprise Value(EV) 9,127.30 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 20.02 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 17.80 Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 107.32 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.32 Calculated using Price: 356.40
Dividend Yield 0.42 Period Ending 2022-03
No. of Shares Subscribed 24.20 Cr. 242,042,756 Shares
FaceValue 1
Company Profile
Granules India is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India today. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs).

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.35%
1 Week
-1.10%
1 Month
+0.61%
3 Month
+16.42%
6 Month
+40.39%
1 Year
+13.26%
2 Year
-13.92%
5 Year
+185.05%
10 Year
+2054.68%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 24.20 23.29 23.53 18.23 10.60 13.32 18.54 27.64 17.49
Return on Capital Employed (%) 19.90 18.81 20.16 16.57 11.09 12.71 17.22 25.42 17.37
Return on Assets (%) 8.98 8.28 9.03 8.12 5.13 6.64 9.99 15.84 10.04

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 356 431 662 904 1,304 1,529 1,844 2,173 2,587 2,598
Non Curr. Liab. 344 357 247 188 488 553 486 366 283 242
Curr. Liab. 293 415 655 787 878 896 893 1,173 1,642 2,017
Minority Int. 1
Equity & Liab. 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,858
Non Curr. Assets 612 700 745 1,051 1,484 1,696 1,594 1,716 2,007 2,129
Curr. Assets 377 500 818 828 1,187 1,282 1,629 1,997 2,505 2,729
Misc. Exp. not W/O 4 3
Total Assets 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,858

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1,096 1,294 1,357 1,411 1,685 2,279 2,599 3,238 3,765 4,197
Other Income 4 4 6 10 11 27 37 27 18 18
Total Income 1,100 1,297 1,363 1,420 1,695 2,306 2,635 3,264 3,783 4,215
Total Expenditure -938 -1,084 -1,081 -1,112 -1,406 -1,895 -2,073 -2,382 -3,043 -3,376
PBIDT 163 213 282 309 289 411 562 882 740 839
Interest -20 -32 -37 -32 -33 -28 -27 -26 -23 -31
Depreciation -30 -53 -58 -72 -76 -105 -137 -151 -159 -167
Taxation -37 -37 -61 -65 -63 -89 -116 -155 -145 -157
Exceptional Items 28
PAT 75 91 125 140 117 188 310 549 413 485
Minority Interest
Share Associate -2 25 16 49 25
Other Related Items
Consolidated Net Profit 75 91 123 165 133 236 335 549 413 485
Adjusted EPS 4 4 6 7 5 9 13 22 17 20

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 91 108 150 151 188 -1 262 476 432 332
Cash Fr. Inv. -128 -255 -146 -162 -326 -462 -270 -161 -277 -380
Cash Fr. Finan. 46 147 19 86 56 529 -17 -213 -299 190
Net Change 10 0 24 75 -82 66 -25 103 -144 142
Cash & Cash Eqvt 42 42 65 130 42 108 83 186 42 185

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 42.04 42.04 42.04 42.04 42.04 41.98 41.98 41.98 41.93
Public 57.96 57.96 57.96 57.96 57.96 58.02 58.02 58.02 58.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 8.64 8.64 8.64 6.92 6.92 6.92 6.92 10.59 10.59

Announcements View Details >>

Tue, 22 Nov 2022
Loss of share certificate
Granules India Limited has informed the Exchange about Information regarding the issuance of a Letter of Confirmation in lieu of a duplicate share certificate.
Mon, 21 Nov 2022
Loss of share certificate
Granules India Limited has informed the Exchange about Information regarding the issuance of a Letter of Confirmation in lieu of a duplicate share certificate.
Fri, 11 Nov 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Granules India Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Fri, 25 Nov 2022
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months
High Increase 5 Years High Increase 5 Years
CCI Oversold Zone CCI Oversold Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Granules India Ltd.

What is Granules India share price?

Can I buy Granules India shares now?

What is the Dividend Yield of Granules India?

What is the Market Cap of Granules India?

What are the key metrics to analyse Granules India?

What is the 52 Week High and Low of Granules India?

What is the trend of Granules India share price?